Baidu
map

福布斯发布《2015美国更佳雇主500强》,百特为制药领域就职圣地

2015-03-27 佚名 生物谷

近日福布斯首次发布《2015美国最佳雇主TOP 500》榜单,互联网巨头谷歌、零售业巨头好市多(Costco Wholesale)、石油巨头马拉松石油(Marathon Petroleum)位列榜单前三甲,成为美国大众心目中最理想的就职企业。前10名的其他企业还包括:货柜商店(The Container Store)、里昂比恩(L.L.BEAN)、百特国际(Baxter International

近日福布斯首次发布《2015美国最佳雇主TOP 500》榜单,互联网巨头谷歌、零售业巨头好市多(Costco Wholesale)、石油巨头马拉松石油(Marathon Petroleum)位列榜单前三甲,成为美国大众心目中最理想的就职企业。前10名的其他企业还包括:货柜商店(The Container Store)、里昂比恩(L.L.BEAN)、百特国际(Baxter International)、宝马集团(BMW Group)、肖氏工业集团(Shaw Industries)、韦格曼斯食品超市(Wegmans Food Markets)、哈雷戴维森公司(Harley-Davidson)。

其中,百特国际是唯一挤进前10名的药企,成为制药及生物技术领域的求职圣地。而该领域,位列2、3位的是肿瘤巨头罗氏(Roche)和最大合同研究组织(CRO)昆泰(Quintilies),在总榜单中分别位列第30和36位。英国2大制药巨头葛兰素史克(GSK)和阿斯利康(AZN)、默沙东,在总榜单中几乎垫底。

以下是《制药及生物技术》领域各巨头详细排名:



完整榜单详见:Forbes:America's Best Employers

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=56274, encodeId=e6e8562e460, content=不了解百特,, beContent=null, objectType=article, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:31:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56275, encodeId=8a7d562e5f9, content=不了解百特,, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:31:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56276, encodeId=3799562e6d3, content=不了解百特,, beContent=null, objectType=article, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:31:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56278, encodeId=26e6562e80b, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:31:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56279, encodeId=cb98562e9a7, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:31:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1405414, encodeId=d09e140541441, content=<a href='/topic/show?id=1960e467287' target=_blank style='color:#2F92EE;'>#福布斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74672, encryptionId=1960e467287, topicName=福布斯)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/iauQrVAlcY8aEJHrvOlmLCVBwvib3FD7qTK78yugrQBRibZokBC8yjXErtdo83kC7EdJjDS1azWzoDnGkrHEroiaJA/132, createdBy=bcef2544989, createdName=zhaozhouchifen, createdTime=Sun Mar 29 00:16:00 CST 2015, time=2015-03-29, status=1, ipAttribution=)]
    2016-01-12 medsic

    不了解百特,

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=56274, encodeId=e6e8562e460, content=不了解百特,, beContent=null, objectType=article, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:31:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56275, encodeId=8a7d562e5f9, content=不了解百特,, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:31:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56276, encodeId=3799562e6d3, content=不了解百特,, beContent=null, objectType=article, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:31:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56278, encodeId=26e6562e80b, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:31:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56279, encodeId=cb98562e9a7, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:31:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1405414, encodeId=d09e140541441, content=<a href='/topic/show?id=1960e467287' target=_blank style='color:#2F92EE;'>#福布斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74672, encryptionId=1960e467287, topicName=福布斯)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/iauQrVAlcY8aEJHrvOlmLCVBwvib3FD7qTK78yugrQBRibZokBC8yjXErtdo83kC7EdJjDS1azWzoDnGkrHEroiaJA/132, createdBy=bcef2544989, createdName=zhaozhouchifen, createdTime=Sun Mar 29 00:16:00 CST 2015, time=2015-03-29, status=1, ipAttribution=)]
    2016-01-12 medsic

    不了解百特,

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=56274, encodeId=e6e8562e460, content=不了解百特,, beContent=null, objectType=article, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:31:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56275, encodeId=8a7d562e5f9, content=不了解百特,, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:31:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56276, encodeId=3799562e6d3, content=不了解百特,, beContent=null, objectType=article, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:31:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56278, encodeId=26e6562e80b, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:31:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56279, encodeId=cb98562e9a7, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:31:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1405414, encodeId=d09e140541441, content=<a href='/topic/show?id=1960e467287' target=_blank style='color:#2F92EE;'>#福布斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74672, encryptionId=1960e467287, topicName=福布斯)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/iauQrVAlcY8aEJHrvOlmLCVBwvib3FD7qTK78yugrQBRibZokBC8yjXErtdo83kC7EdJjDS1azWzoDnGkrHEroiaJA/132, createdBy=bcef2544989, createdName=zhaozhouchifen, createdTime=Sun Mar 29 00:16:00 CST 2015, time=2015-03-29, status=1, ipAttribution=)]
    2016-01-12 medsic

    不了解百特,

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=56274, encodeId=e6e8562e460, content=不了解百特,, beContent=null, objectType=article, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:31:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56275, encodeId=8a7d562e5f9, content=不了解百特,, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:31:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56276, encodeId=3799562e6d3, content=不了解百特,, beContent=null, objectType=article, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:31:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56278, encodeId=26e6562e80b, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:31:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56279, encodeId=cb98562e9a7, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:31:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1405414, encodeId=d09e140541441, content=<a href='/topic/show?id=1960e467287' target=_blank style='color:#2F92EE;'>#福布斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74672, encryptionId=1960e467287, topicName=福布斯)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/iauQrVAlcY8aEJHrvOlmLCVBwvib3FD7qTK78yugrQBRibZokBC8yjXErtdo83kC7EdJjDS1azWzoDnGkrHEroiaJA/132, createdBy=bcef2544989, createdName=zhaozhouchifen, createdTime=Sun Mar 29 00:16:00 CST 2015, time=2015-03-29, status=1, ipAttribution=)]
    2016-01-12 medsic

    感谢分享~~

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=56274, encodeId=e6e8562e460, content=不了解百特,, beContent=null, objectType=article, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:31:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56275, encodeId=8a7d562e5f9, content=不了解百特,, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:31:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56276, encodeId=3799562e6d3, content=不了解百特,, beContent=null, objectType=article, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:31:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56278, encodeId=26e6562e80b, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:31:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56279, encodeId=cb98562e9a7, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:31:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1405414, encodeId=d09e140541441, content=<a href='/topic/show?id=1960e467287' target=_blank style='color:#2F92EE;'>#福布斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74672, encryptionId=1960e467287, topicName=福布斯)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/iauQrVAlcY8aEJHrvOlmLCVBwvib3FD7qTK78yugrQBRibZokBC8yjXErtdo83kC7EdJjDS1azWzoDnGkrHEroiaJA/132, createdBy=bcef2544989, createdName=zhaozhouchifen, createdTime=Sun Mar 29 00:16:00 CST 2015, time=2015-03-29, status=1, ipAttribution=)]
    2016-01-12 medsic

    感谢分享~~

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=56274, encodeId=e6e8562e460, content=不了解百特,, beContent=null, objectType=article, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:31:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56275, encodeId=8a7d562e5f9, content=不了解百特,, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:31:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56276, encodeId=3799562e6d3, content=不了解百特,, beContent=null, objectType=article, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:31:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56278, encodeId=26e6562e80b, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:31:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56279, encodeId=cb98562e9a7, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:31:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1405414, encodeId=d09e140541441, content=<a href='/topic/show?id=1960e467287' target=_blank style='color:#2F92EE;'>#福布斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74672, encryptionId=1960e467287, topicName=福布斯)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/iauQrVAlcY8aEJHrvOlmLCVBwvib3FD7qTK78yugrQBRibZokBC8yjXErtdo83kC7EdJjDS1azWzoDnGkrHEroiaJA/132, createdBy=bcef2544989, createdName=zhaozhouchifen, createdTime=Sun Mar 29 00:16:00 CST 2015, time=2015-03-29, status=1, ipAttribution=)]
Baidu
map
Baidu
map
Baidu
map